B
BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible. Our proprietary molecular counting platform can accurately count DNA molecules at the single-count level to help improve disease detection.
Investor insights
Funding rounds participated in
$130M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
2016
Funding rounds raised
Total raised
$130M
from 2 investors over 1 rounds
B
BillionToOne raised $130M on July 21, 2024
Investors: Premji Invest and + 6 Other investors